Frontier Insight
The most pressing topics and technology trends shaping the global women's health industry and capital landscape today.
Full Programme · 2026
A high-level cross-border platform convening industry, capital, clinical, research and policy leaders across women’s health. Day 1 is the flagship public conference; Days 2–4 unfold as a closed-door pitch day, investor 1:1s and curated ecosystem visits.
A working agenda built around insight, exchange and practical takeaways.
The most pressing topics and technology trends shaping the global women's health industry and capital landscape today.
Voices from clinical, industry, capital and policy meet to explore broad applications of women's health technology and innovation.
Front-line investors, founders and clinical / medtech leaders share what worked, what didn't, and what they would do differently.
Capital flow, industrial collaboration and China momentum in global women's health innovation
Registration & Networking
Opening Remarks
Keynote: China as a Strategic Hub for Women's Health Innovation· tentative
Shanghai Pudong New Area Government (TBC)
Keynote: From Margin to Mainstream — Future Opportunities in Global Women's Health
PwC
Keynote: Investing in Women's Health — Why the Market is Now
Amboy Street Ventures
Panel: The Commercial and Social Value of Investing in Women's Health
Fortune Capital, Highlight Capital and overseas investors
Keynote: FemTech and the Rise of the Global Women's Health Industry
Ida Tin, Founder of Clue
Panel: A Global Map of Women's Health Innovation — What Different Markets Are Building, and Why It Matters
Keynote: From China to Global — Clinical Innovation in Women's Health· tentative
Academician Zhu Lan / Nick Morse
Panel: Patient-Centred Innovation in Women's Health
Keynote: Industry Forces Powering the Women's Health Ecosystem
Bayer Women's Healthcare
Cross-border deals and ecosystem synergy — applied innovation in women's health
Fireside: Policy-Led Cross-Border Collaboration — Consulates and Ecosystem Builders Driving Women's Health Innovation· tentative
Denmark, Canada and UK Consulates
Keynote: China's ART Innovation — IVF, Scale and Global Relevance· tentative
Keynote: Beyond Reproductive Health — Expanding the Frontier of Women's Health Innovation· tentative
Panel: Blind Spots in Women's Health — Conditions Still Overlooked, Underserved and Underfunded
Panel: Engineering Women's Health — Devices, Diagnostics and Clinical Adoption· tentative
Keynote: From Consumer Insight to Market Growth — Trends and Opportunities in Women's Health Demand· tentative
Panel: AI-Enabled Women's Health — Opportunities, Data Challenges and Real-World Pathways
Keynote: Beyond Period Tracking — The Past, Present and Future of China's Women's Health Innovation· tentative
Chai Ke, Founder of Dayima
Pitch Sessions
Registration & Networking
Opening Remarks by Bayer Healthcare (China)
Pitch Session 1 — Clinical / Digital Health · 6 × 15 min
Tea Break
Pitch Session 2 — Clinical / Digital Health · 6 × 15 min
Investor 1:1 Meetings
Founders meet at least 5 investors
Group Discussion
Government-guided ecosystem visits for international women's health companies — including park and enterprise tours, closed-door workshops, and cultural exchange.
A coalition of host organisations, government guidance and strategic partners shaping this convening.
Host Organisations
Guidance Units
Strategic Partners (in no particular order)